Cornea/External Disease News

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.

The FDA approved the Deseyne daily disposable contact lens, which steadily releases bioactive substances that improve hydration and aid comfort, according to a press release from Bruno Vision Care.

In eyes with keratoconus, no contact lens — whether soft, gas permeable or scleral — can arrest progression of the underlying disease process, even when it does achieve the goal of helping the patient see better.

Older patients were more likely to have microbial contamination in their therapeutic contact lenses following PRK, according to a study published in Journal of Ophthalmic Inflammation and Infection.

  The FDA issued a complete response letter for the resubmission of the reproxalap new drug application for the treatment of signs and symptoms of dry eye disease, according to a press release from Aldeyra Therapeutics.

Miebo produced substantial symptom relief in patients with dry eye disease during the first day and succeeding weeks of treatment, according to a study published in Ophthalmology and Therapy.

ORLANDO — Lumenis announced the launch of OptiLift, a dynamic muscle stimulation technology intended to improve lower eyelid laxity, blink quality and eyelid function, at Vision Expo East.

 Alcon has acquired a majority interest in Aurion Biotech, according to a press release.

ATHENS, Greece — Implantation of customized lenticules could offer a tailored solution for corneal remodeling in eccentric keratoconus, according to an ex vivo study.